243 related articles for article (PubMed ID: 19141127)
41. Correlation of [18F]-2-fluoro-deoxy-D-glucose positron emission tomography standard uptake values with the cellular composition of stage I nonsmall cell lung cancer.
Christensen JD; Colby TV; Patz EF
Cancer; 2010 Sep; 116(17):4095-102. PubMed ID: 20533438
[TBL] [Abstract][Full Text] [Related]
42. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
[TBL] [Abstract][Full Text] [Related]
43. Maximal standardized uptake value on FDG-PET is correlated with cyclooxygenase-2 expression in patients with lung adenocarcinoma.
Shimizu K; Hirami Y; Saisho S; Yukawa T; Maeda A; Yasuda K; Nakata M
Ann Thorac Surg; 2012 Feb; 93(2):398-403. PubMed ID: 22206958
[TBL] [Abstract][Full Text] [Related]
44. Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery.
Lopci E; Toschi L; Grizzi F; Rahal D; Olivari L; Castino GF; Marchetti S; Cortese N; Qehajaj D; Pistillo D; Alloisio M; Roncalli M; Allavena P; Santoro A; Marchesi F; Chiti A
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1954-61. PubMed ID: 27251642
[TBL] [Abstract][Full Text] [Related]
45. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
Furukawa T; Miyata Y; Kushitani K; Mimae T; Tsutani Y; Takeshima Y; Okada M
Jpn J Clin Oncol; 2015 Dec; 45(12):1154-61. PubMed ID: 26386467
[TBL] [Abstract][Full Text] [Related]
46. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.
Brown RS; Leung JY; Kison PV; Zasadny KR; Flint A; Wahl RL
J Nucl Med; 1999 Apr; 40(4):556-65. PubMed ID: 10210213
[TBL] [Abstract][Full Text] [Related]
47. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Serizawa M; Koh Y; Hanaoka H; Tominaga H; Oriuchi N; Kondo H; Nakajima T; Yamamoto N
J Clin Oncol; 2010 Aug; 28(23):3746-53. PubMed ID: 20625125
[TBL] [Abstract][Full Text] [Related]
48. Biological correlates of FDG uptake in non-small cell lung cancer.
de Geus-Oei LF; van Krieken JH; Aliredjo RP; Krabbe PF; Frielink C; Verhagen AF; Boerman OC; Oyen WJ
Lung Cancer; 2007 Jan; 55(1):79-87. PubMed ID: 17046099
[TBL] [Abstract][Full Text] [Related]
49. Microvessel density but not neoangiogenesis is associated with 18F-FDG uptake in human atherosclerotic carotid plaques.
Pedersen SF; Graebe M; Hag AM; Hoejgaard L; Sillesen H; Kjaer A
Mol Imaging Biol; 2012 Jun; 14(3):384-92. PubMed ID: 21732164
[TBL] [Abstract][Full Text] [Related]
50. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.
Nobusawa A; Kim M; Kaira K; Miyashita G; Negishi A; Oriuchi N; Higuchi T; Tsushima Y; Kanai Y; Yokoo S; Oyama T
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1692-700. PubMed ID: 23801167
[TBL] [Abstract][Full Text] [Related]
52. Relationship between cancer cell proliferation, tumour angiogenesis and 201Tl uptake in non-small cell lung cancer.
Fujita S; Nagamachi S; Nishii R; Wakamatsu H; Futami S; Tamura S; Matsuzaki Y; Onizuka T; Hatakeyama K; Asada Y
Nucl Med Commun; 2006 Dec; 27(12):989-97. PubMed ID: 17088685
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer.
Abe K; Baba S; Kaneko K; Isoda T; Yabuuchi H; Sasaki M; Sakai S; Yoshino I; Honda H
Clin Imaging; 2009; 33(2):90-5. PubMed ID: 19237050
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.
Goodgame B; Pillot GA; Yang Z; Shriki J; Meyers BF; Zoole J; Gao F; Dehdashti F; Patterson A; Siegel BA; Govindan R
J Thorac Oncol; 2008 Feb; 3(2):130-4. PubMed ID: 18303432
[TBL] [Abstract][Full Text] [Related]
55. Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Taylor MD; Smith PW; Brix WK; Wick MR; Theodosakis N; Swenson BR; Kozower BD; Lau CL; Jones DR
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):43-8. PubMed ID: 19154901
[TBL] [Abstract][Full Text] [Related]
56. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
[TBL] [Abstract][Full Text] [Related]
57. Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study.
van Baardwijk A; Bosmans G; van Suylen RJ; van Kroonenburgh M; Hochstenbag M; Geskes G; Lambin P; De Ruysscher D
Radiother Oncol; 2008 Apr; 87(1):55-8. PubMed ID: 18328584
[TBL] [Abstract][Full Text] [Related]
58. Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.
Kaira K; Serizawa M; Koh Y; Takahashi T; Hanaoka H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
Eur J Cancer; 2012 May; 48(8):1244-54. PubMed ID: 22330319
[TBL] [Abstract][Full Text] [Related]
59. Lymph node staging in lung cancer using [18F]FDG-PET.
Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN
Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography.
Choi JY; Jang KT; Shim YM; Kim K; Ahn G; Lee KH; Choi Y; Choe YS; Kim BT
Ann Surg Oncol; 2006 Aug; 13(8):1054-62. PubMed ID: 16865594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
